Human prostate tumor angiogenesis in nude mice: Metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected Matrigel impregnated with human prostate tumor cells

Anatomical Record

Volumn 249, Issue 1, 1997, Pages 63-73

  Wilson, Michael J ^a,b   Sinha, Akhouri A ^a,b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Angiogenesis; Gelatinase A; Prostate cancer; Prostate specific antigen; Urokinase

Indexed keywords

MATRIGEL; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; UROKINASE; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE TUMOR; SOLID TUMOR; TUMOR CELL CULTURE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CASEINS; COLLAGEN; DRUG COMBINATIONS; ENDOPEPTIDASES; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; LAMININ; MALE; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATORS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEOGLYCANS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ANIMALIA; MUS MUSCULUS;

EID: 0030852410     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0185(199709)249:1<63::AID-AR8>3.0.CO;2-G     Document Type: Article

References (43)

1. Bigler, S.A., R.E. Deering, and M.K. Brawer 1993 Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum. Pathol., 24:220-226.
2. Bonfil, R.D., A. Vinyals, O.D. Bustuoabad, A. Llorens, F.J. Benavides, M. Gonzalez-Garrigues, and A. Fabra 1994 Stimulation of angiogenesis as an explanation of matrigel-enhanced tumorigenicity. Int J Cancer 58:233-239.
3. Brawer, M.K., S.A. Bigler, and R.E. Deering 1992 Quantitative morphometric analysis of the microcirculation in prostate carcinoma. J. Cell. Biochem. (Suppl.), 16H:62-64.
4. Brawer, M.K., R.E. Deering, M. Brown, S.D. Preston, and S.A. Bigler 1994 Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer, 73:678-687.
5. Brown, L.F., K.-T. Yeo, B. Berse, A. Morgentaler, H.F. Dvorak, and S. Rosen 1995 Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. J. Urol., 154:576-579.
6. Culig, Z., A. Hobisch, M.V. Cronauer, C. Radmayr, A. Hittmair, J. Zhang, M. Thurnher, G. Bartsch, and H. Klocker 1996 Regulation of prosotatic growth and function by peptide growth factors. Prostate, 28:392-405.
7. Dvorak, H.F., J.A. Nagy, J.T. Dvorak, and A.M. Dvorak 1988 Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol., 133:95-109.
8. Fan, T.-P.D., R. Jaggar, and R. Bicknell 1995 Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. TIPS, 16:57-66.
9. Folkman, J., and Y. Shing 1992 Angiogenesis. J. Biol. Chem., 267:10931-10934.
10. Fu, X., H. Herrera, and R.M. Hoffman 1992 Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int. J. Cancer, 52:987-990.
11. Furusato, M., S. Wakui, H. Sasaki, K. Ito, and S. Ushigome 1994 Tumor angiogenesis in latent prostatic carcinoma. Br. J. Cancer, 70:1244-1246.
12. Gaylis, F.D., H.N. Keer, M.J. Wilson, H.C. Kwaan, A.A. Sinha, and J.M. Kozlowski 1989 Plasminogen activators in human prostate cancer cell lines and tumors: Correlation with the aggressive phenotype. J. Urol., 142:193-198.
13. Gleave, M., J.-T. Hsieh, C. Gao, A.C. von Eschenbach, and L.W.K. Chung LWK 1991 Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51:3753-3761.
14. Heusen, C., and E.B. Dowdle 1980 Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl-sulfate and copolymerized substrates. Anal. Biochem., 102:186-202.
15. Kibbey, M.C., D.S. Grant, and H.K. Kleinman 1992 Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: An in vivo Matrigel model. J. Natl. Cancer Inst., 84:1633-1638.
16. Klagsbrun, M., and P.A. D'Amore 1991 Regulators of angiogenesis. Ann. Rev. Physiol., 53:217-239.
17. Lim, D.J.L., Z.L. Liu, D.M. Sutkowski, E.J. Braun, C. Lee, and J.M. Kozlowski 1993 Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate, 22:109-118.
18. Mackay, A.R., D.E. Gomez, D.W. Cottam, R.C. Rees, A.M. Nason, and U.P. Thorgeirsson 1993 Identification of the 72-kDa (MMP-2) and 92-kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and Matrigel. Biotechniques, 15:1048-1051.
19. McGuire, P.G., and N.W. Seeds 1989 The interaction of plasminogen activator with a reconstituted basement membrane matrix and extracellular macromolecules produced by cultured epithelial cells. J. Cell. Biochem., 40:215-227.
20. Meyer, K.D., G. Pietu, E. Fressinaud, and J.-P. Girma 1991 Von Willebrand factor: Structure and function. Mayo Clin. Proc., 66:516-523.
21. Montironi, R., C. Magi Galluzzi, L. Diamanti, R. Taborro, M. Scarpelli, and E. Pisani 1993 Prostatic intra-epithelial neoplasia: qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Path. Res. Pract., 189:542-548.
22. Nguyen, N.M., J.E. Lehr, and K.J. Pienta 1993 Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Anticancer Res., 13:2143-2148.
23. Paku, S., and K. Lapis 1993 Morphological aspects of angiogenesis in experimental liver metastases. Am. J. Pathol., 143:926-936.
24. Passaniti, A., J.T. Isaacs, J.A. Haney, S.W. Adler, T.J. Cujdik, P.V. Long, and H.K. Kleinman 1992a Stimulation of human prostatic carcinoma tumor growth in athymic nude mice and control of migration in culture by extracellular matrix. Int. J. Cancer, 51:318-324.
25. Passaniti, A., R.M. Taylor, R. Pili, Y. Guo, P.V. Long, J.A. Haney, R.R. Pauly, D.S. Grant, and G.R. Martin 1992b A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest., 67:519-528.
26. Pretlow, T.G., C.M. Delmoro, G.G. Dilley, C.G. Spadafora, and T.P. Pretlow 1991 Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res., 51:3814-3817.
27. Rand, J.H., X.-X. Wu, B.J. Potter, R.R. Uson, and R.E. Gordon 1993 Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium. Am. J. Pathol., 143:843-850.
28. Sinha, A.A., G.F. Gleason, C. Limas, P.K. Reddy, M.R. Wick, K.A. Hagen, and M.J. Wilson 1989 Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A-gold technique. Anat. Rec., 223:266-276.
29. Sinha, A.A., M.J. Wilson, D.F. Gleason, P.K. Reddy, M. Sameni, and B.F. Sloane 1995a Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate, 26:171-178.
30. Sinha, A.A., D.F. Gleason, N.A. Staley, M.J. Wilson, M. Sameni, and B.F. Sloane 1995b Cathepsin B in angiogenesis of human prostate: An immunohistochemical and immunoelectron microscopic analysis. Anat. Rec., 241:353-362.
31. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk 1985 Measurement of protein using bicinchoninic acid. Anal. Biochem., 150:76-85.
32. Stephenson, R.A., C.P.N. Dinney, K. Gohji, N.G. Ordonez, J.J. Killion, and I.J. Fidler 1992 Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst., 84:951-957.
33. Sunderkotter, C., K. Steinbrink, M. Goebeler, R. Bhardwaj, and C. Sorg 1994 Macrophages and angiogenesis. J. Leukoc. Biol., 55:410-422.
34. Taraboletti, G., A. Garofalo, D. Belotti, T. Drudis, P. Borsotti, E. Scanzianni, P.D. Brown, and R. Giavazzi 1995 Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst., 87:293-298.
35. van Hinsbergh, V.W.M., R. Hanemaaijer, and P. Koolwijk 1994 Endothelial plasminogen activators and matrix metalloproteinases in fibrinolysis and local proteolysis. In: Angiogenesis: Molecular Biology, Clinical Aspects. M.W. Maragoudakis, P.M. Gullino, and P.I. Lelkes, eds. Plenum Press, New York, pp. 171-181.
36. Vukanovic, J., and J.T. Isaacs 1995 Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res., 55:1499-1504.
37. Vukanovic, J., B. Hartley-Asp, and J.T. Isaacs 1995 Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers. Prostate, 26:235-246.
38. Waters, D.J., E.B. Janovitz, and T.C.K. Chan 1995 Spontaneous metastasis of PC-3 cells in athymic mice after implantation in orthotopic or ectopic microenvironments. Prostate, 26:227-234.
39. Weidner, N., P.R. Carroll, J. Flax, W. Buenfeld, and J. Folkman 1993 Tumor angiogenesis correlates with metastasis in invasive prostatic carcinoma. Am. J. Pathol., 143:401-409.
40. Wilson, M.J., and A.A. Sinha 1993 Plasminogen activator and metalloprotease activities of Du-145, PC-3, and 1-LN-PC-3-1A human prostate tumors grown in nude mice: Correlation with tumor invasive behavior. Cell. Mol. Biol. Res., 39:751-760.
41. Wilson, M.J., A.A. Sinha, J.E.H. Powell, and R.D. Estensen 1988 Plasminogen activator activities in the developing rat prostate. Biol. Reprod., 38:723-731.
42. Wilson, M.J., B. Garcia, M. Woodson, and A.A. Sinha 1992 Metalloprotease activities expressed during development and maturation of the rat prostatic complex and seminal vesicles. Biol. Reprod., 47:683-691.
43. Yamaoka, M., T. Yamamoto, S. Ikeyama, K. Sudo, and T. Fujita 1993 Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res., 53:5233-5236.